1
|
Hu N, Nakao M, Ozawa S, Takata T, Tanaka H, Nihei K, Ono K, Suzuki M. Application of stoichiometric CT number calibration method for dose calculation of tissue heterogeneous volumes in boron neutron capture therapy. Med Phys 2024; 51:4413-4422. [PMID: 38669482 DOI: 10.1002/mp.17093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2023] [Revised: 04/09/2024] [Accepted: 04/10/2024] [Indexed: 04/28/2024] Open
Abstract
BACKGROUND Monte Carlo simulation code is commonly used for the dose calculation of boron neutron capture therapy. In the past, dose calculation was performed assuming a homogeneous mass density and elemental composition inside the tissue, regardless of the patient's age or sex. Studies have shown that the mass density varies with patient to patient, particularly for those that have undergone surgery or radiotherapy. A method to convert computed tomography numbers into mass density and elemental weights of tissues has been developed and applied in the dose calculation process using Monte Carlo codes. A recent study has shown the variation in the computed tomography number between different scanners for low- and high-density materials. PURPOSE The aim of this study is to investigate the effect of the elemental composition inside each calculation voxel on the dose calculation and the application of the stoichiometric CT number calibration method for boron neutron capture therapy planning. METHODS Monte Carlo simulation package Particle and Heavy Ion Transport code System was used for the dose calculation. Firstly, a homogeneous cubic phantom with the material set to ICRU soft tissue (four component), muscle, fat, and brain was modelled and the NeuCure BNCT system accelerator-based neutron source was used. The central axis depth dose distribution was simulated and compared between the four materials. Secondly, a treatment plan of the brain and the head and neck region was simulated using a dummy patient dataset. Three models were generated; (1) a model where only the fundamental materials were considered (simple model), a model where each voxel was assigned a mass density and elemental weight using (2) the Nakao20 model, and (3) the Schneider00 model. The irradiation conditions were kept the same between the different models (irradiation time and irradiation field size) and the near maximum (D1%) and mean dose to the organs at risk were calculated and compared. RESULTS A maximum percentage difference of approximately 5% was observed between the different materials for the homogeneous phantom. With the dummy patient plan, a large dose difference in the bone (greater than 12%) and region near the low-density material (mucosal membrane, 7%-11%) was found between the different models. CONCLUSIONS A stoichiometric CT number calibration method using the newly developed Nakao20 model was applied to BNCT dose calculation. The results indicate the importance of calibrating the CT number to elemental composition for each individual CT scanner for the purpose of BNCT dose calculation along with the consideration of heterogeneity of the material composition inside the defined region of interest.
Collapse
Affiliation(s)
- Naonori Hu
- Institute for Integrated Radiation and Nuclear Science, Kyoto University, Sennangun, Osaka, Japan
- Kansai BNCT Medical Center, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan
| | - Minoru Nakao
- Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Department of Radiation Oncology, Hiroshima University, Hiroshima, Japan
| | - Shuichi Ozawa
- Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Department of Radiation Oncology, Hiroshima University, Hiroshima, Japan
| | - Takushi Takata
- Institute for Integrated Radiation and Nuclear Science, Kyoto University, Sennangun, Osaka, Japan
| | - Hiroki Tanaka
- Institute for Integrated Radiation and Nuclear Science, Kyoto University, Sennangun, Osaka, Japan
| | - Keiji Nihei
- Kansai BNCT Medical Center, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan
- Department of Radiation Oncology, Osaka Medical and Pharmaceutical University Hospital, Takatsuki, Osaka, Japan
| | - Koji Ono
- Kansai BNCT Medical Center, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan
| | - Minoru Suzuki
- Institute for Integrated Radiation and Nuclear Science, Kyoto University, Sennangun, Osaka, Japan
| |
Collapse
|
2
|
Nakao M, Ozawa S, Miura H, Yamada K, Hayata M, Hayashi K, Kawahara D, Nakashima T, Ochi Y, Okumura T, Kunimoto H, Kawakubo A, Kusaba H, Nozaki H, Habara K, Tohyama N, Nishio T, Nakamura M, Minemura T, Okamoto H, Ishikawa M, Kurooka M, Shimizu H, Hotta K, Saito M, Nakano M, Tsuneda M, Nagata Y. CT number calibration audit in photon radiation therapy. Med Phys 2024; 51:1571-1582. [PMID: 38112216 DOI: 10.1002/mp.16887] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2023] [Revised: 06/29/2023] [Accepted: 11/26/2023] [Indexed: 12/21/2023] Open
Abstract
BACKGROUND Inadequate computed tomography (CT) number calibration curves affect dose calculation accuracy. Although CT number calibration curves registered in treatment planning systems (TPSs) should be consistent with human tissues, it is unclear whether adequate CT number calibration is performed because CT number calibration curves have not been assessed for various types of CT number calibration phantoms and TPSs. PURPOSE The purpose of this study was to investigate CT number calibration curves for mass density (ρ) and relative electron density (ρe ). METHODS A CT number calibration audit phantom was sent to 24 Japanese photon therapy institutes from the evaluating institute and scanned using their individual clinical CT scan protocols. The CT images of the audit phantom and institute-specific CT number calibration curves were submitted to the evaluating institute for analyzing the calibration curves registered in the TPSs at the participating institutes. The institute-specific CT number calibration curves were created using commercial phantom (Gammex, Gammex Inc., Middleton, WI, USA) or CIRS phantom (Computerized Imaging Reference Systems, Inc., Norfolk, VA, USA)). At the evaluating institute, theoretical CT number calibration curves were created using a stoichiometric CT number calibration method based on the CT image, and the institute-specific CT number calibration curves were compared with the theoretical calibration curve. Differences in ρ and ρe over the multiple points on the curve (Δρm and Δρe,m , respectively) were calculated for each CT number, categorized for each phantom vendor and TPS, and evaluated for three tissue types: lung, soft tissues, and bones. In particular, the CT-ρ calibration curves for Tomotherapy TPSs (ACCURAY, Sunnyvale, CA, USA) were categorized separately from the Gammex CT-ρ calibration curves because the available tissue-equivalent materials (TEMs) were limited by the manufacturer recommendations. In addition, the differences in ρ and ρe for the specific TEMs (ΔρTEM and Δρe,TEM , respectively) were calculated by subtracting the ρ or ρe of the TEMs from the theoretical CT-ρ or CT-ρe calibration curve. RESULTS The mean ± standard deviation (SD) of Δρm and Δρe,m for the Gammex phantom were -1.1 ± 1.2 g/cm3 and -0.2 ± 1.1, -0.3 ± 0.9 g/cm3 and 0.8 ± 1.3, and -0.9 ± 1.3 g/cm3 and 1.0 ± 1.5 for lung, soft tissues, and bones, respectively. The mean ± SD of Δρm and Δρe,m for the CIRS phantom were 0.3 ± 0.8 g/cm3 and 0.9 ± 0.9, 0.6 ± 0.6 g/cm3 and 1.4 ± 0.8, and 0.2 ± 0.5 g/cm3 and 1.6 ± 0.5 for lung, soft tissues, and bones, respectively. The mean ± SD of Δρm for Tomotherapy TPSs was 2.1 ± 1.4 g/cm3 for soft tissues, which is larger than those for other TPSs. The mean ± SD of Δρe,TEM for the Gammex brain phantom (BRN-SR2) was -1.8 ± 0.4, implying that the tissue equivalency of the BRN-SR2 plug was slightly inferior to that of other plugs. CONCLUSIONS Latent deviations between human tissues and TEMs were found by comparing the CT number calibration curves of the various institutes.
Collapse
Affiliation(s)
- Minoru Nakao
- Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Department of Radiation Oncology, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
| | - Shuichi Ozawa
- Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Department of Radiation Oncology, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
| | - Hideharu Miura
- Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Department of Radiation Oncology, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
| | - Kiyoshi Yamada
- Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
| | - Masahiro Hayata
- Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
| | - Kosuke Hayashi
- Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
| | - Daisuke Kawahara
- Department of Radiation Oncology, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
| | - Takeo Nakashima
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
- Radiation Therapy Section, Department of Clinical Support, Hiroshima University Hospital, Hiroshima, Japan
| | - Yusuke Ochi
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Radiation Therapy Section, Department of Clinical Support, Hiroshima University Hospital, Hiroshima, Japan
| | - Takuro Okumura
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Radiation Therapy Section, Department of Clinical Support, Hiroshima University Hospital, Hiroshima, Japan
| | - Haruhide Kunimoto
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Radiation Therapy Department, Hiroshima Prefectural Hospital, Hiroshima, Japan
| | - Atsushi Kawakubo
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Radiation Therapy Department, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan
| | - Hayate Kusaba
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Radiation Therapy Department, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan
| | - Hiroshige Nozaki
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Division of Radiology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan
| | - Kosaku Habara
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Division of Radiology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan
| | - Naoki Tohyama
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
- Division of Medical Physics, Tokyo Bay Makuhari Clinic for Advanced Imaging, Cancer Screening, and High-Precision Radiotherapy, Chiba, Japan
| | - Teiji Nishio
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
- Medical Physics Laboratory, Division of Health Science, Graduate School of Medicine, Osaka University, Osaka, Japan
| | - Mitsuhiro Nakamura
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
- Department of Radiation Oncology and Image-Applied Therapy, Kyoto University, Kyoto, Japan
- Department of Advanced Medical Physics, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - Toshiyuki Minemura
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
- Division of Medical Support and Partnership, Institute for Cancer Control, National Cancer Center, Tokyo, Japan
| | - Hiroyuki Okamoto
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
- Radiation Safety and Quality Assurance Division, National Cancer Center Hospital, Tokyo, Japan
| | - Masayori Ishikawa
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
- Faculty of Health Sciences, Hokkaido University, Hokkaido, Japan
| | - Masahiko Kurooka
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
- Department of Radiation Therapy, Tokyo Medical University Hospital, Tokyo, Japan
| | - Hidetoshi Shimizu
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
- Department of Radiation Oncology, Aichi Cancer Center Hospital, Aichi, Japan
| | - Kenji Hotta
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
- Radiation Safety and Quality Assurance division, National Cancer Center Hospital East, Chiba, Japan
- Particle Therapy Division, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Chiba, Japan
| | - Masahide Saito
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
- Department of Radiology, University of Yamanashi, Yamanashi, Japan
| | - Masahiro Nakano
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
- Department of Radiation Oncology, Kitasato University School of Medicine, Kanagawa, Japan
| | - Masato Tsuneda
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
- Graduate School of Medicine, Chiba University, Chiba, Japan
| | - Yasushi Nagata
- Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Department of Radiation Oncology, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
| |
Collapse
|
3
|
Peters N, Taasti VT, Ackermann B, Bolsi A, Dahlgren CV, Ellerbrock M, Fracchiolla F, Gomà C, Góra J, Lopes PC, Rinaldi I, Salvo K, Tarp IS, Vai A, Bortfeld T, Lomax A, Richter C, Wohlfahrt P. Response to "Letter regarding Consensus guide on CT-based prediction of stopping-power ratio using a Hounsfield look-up table for proton therapy". Radiother Oncol 2024; 190:109961. [PMID: 37871749 DOI: 10.1016/j.radonc.2023.109961] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2023] [Accepted: 09/21/2023] [Indexed: 10/25/2023]
Affiliation(s)
- Nils Peters
- OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Germany; Massachusetts General Hospital and Harvard Medical School, Department of Radiation Oncology, Boston, MA, USA.
| | - Vicki Trier Taasti
- Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.
| | - Benjamin Ackermann
- Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany
| | - Alessandra Bolsi
- Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland
| | | | - Malte Ellerbrock
- Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany
| | - Francesco Fracchiolla
- Azienda Provinciale per i Servizi Sanitari (APSS) Protontherapy Department, Trento, Italy
| | - Carles Gomà
- Department of Radiation Oncology, Hospital Clínic de Barcelona, Barcelona, Spain
| | - Joanna Góra
- MedAustron Ion Therapy Center, Wiener Neustadt, Austria
| | | | - Ilaria Rinaldi
- Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands
| | - Koen Salvo
- AZ Sint-Maarten, Department of Radiotherapy, Mechelen, Belgium
| | - Ivanka Sojat Tarp
- Aarhus University Hospital, Danish Center for Particle Therapy, Aarhus, Denmark
| | - Alessandro Vai
- Radiotherapy Department, Center for National Oncological Hadrontherapy (CNAO), 27100 Pavia, Italy
| | - Thomas Bortfeld
- Massachusetts General Hospital and Harvard Medical School, Department of Radiation Oncology, Boston, MA, USA
| | - Antony Lomax
- Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland
| | - Christian Richter
- OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Germany; Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiooncology - OncoRay, Dresden, Germany; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - Patrick Wohlfahrt
- Massachusetts General Hospital and Harvard Medical School, Department of Radiation Oncology, Boston, MA, USA
| |
Collapse
|
4
|
Poludniowski G, Zimmerman J. Letter regarding "Consensus guide on CT-based prediction of stopping-power ratio using a Hounsfield look-up table for proton therapy". Radiother Oncol 2024; 190:109962. [PMID: 37871750 DOI: 10.1016/j.radonc.2023.109962] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2023] [Revised: 08/09/2023] [Accepted: 09/26/2023] [Indexed: 10/25/2023]
Affiliation(s)
- Gavin Poludniowski
- Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden; Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
| | - Jens Zimmerman
- Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
| |
Collapse
|
5
|
Chauvie S, Mazzoni LN, O’Doherty J. A Review on the Use of Imaging Biomarkers in Oncology Clinical Trials: Quality Assurance Strategies for Technical Validation. Tomography 2023; 9:1876-1902. [PMID: 37888741 PMCID: PMC10610870 DOI: 10.3390/tomography9050149] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2023] [Revised: 10/10/2023] [Accepted: 10/13/2023] [Indexed: 10/28/2023] Open
Abstract
Imaging biomarkers (IBs) have been proposed in medical literature that exploit images in a quantitative way, going beyond the visual assessment by an imaging physician. These IBs can be used in the diagnosis, prognosis, and response assessment of several pathologies and are very often used for patient management pathways. In this respect, IBs to be used in clinical practice and clinical trials have a requirement to be precise, accurate, and reproducible. Due to limitations in imaging technology, an error can be associated with their value when considering the entire imaging chain, from data acquisition to data reconstruction and subsequent analysis. From this point of view, the use of IBs in clinical trials requires a broadening of the concept of quality assurance and this can be a challenge for the responsible medical physics experts (MPEs). Within this manuscript, we describe the concept of an IB, examine some examples of IBs currently employed in clinical practice/clinical trials and analyze the procedure that should be carried out to achieve better accuracy and reproducibility in their use. We anticipate that this narrative review, written by the components of the EFOMP working group on "the role of the MPEs in clinical trials"-imaging sub-group, can represent a valid reference material for MPEs approaching the subject.
Collapse
Affiliation(s)
- Stephane Chauvie
- Medical Physics Division, Santa Croce e Carle Hospital, 12100 Cuneo, Italy;
| | | | - Jim O’Doherty
- Siemens Medical Solutions, Malvern, PA 19355, USA;
- Department of Radiology & Radiological Sciences, Medical University of South Carolina, Charleston, SC 20455, USA
- Radiography & Diagnostic Imaging, University College Dublin, D04 C7X2 Dublin, Ireland
| |
Collapse
|
6
|
Zimmerman J, Thor D, Poludniowski G. Stopping-power ratio estimation for proton radiotherapy using dual-energy computed tomography and prior-image constrained denoising. Med Phys 2023; 50:1481-1495. [PMID: 36322128 DOI: 10.1002/mp.16063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2022] [Revised: 09/12/2022] [Accepted: 09/26/2022] [Indexed: 11/06/2022] Open
Abstract
BACKGROUND Dual-energy computed tomography (DECT) is a promising technique for estimating stopping-power ratio (SPR) for proton therapy planning. It is known, however, that deriving electron density (ED) and effective atomic number (EAN) from DECT data can cause noise amplification in the resulting SPR images. This can negate the benefits of DECT. PURPOSE This work introduces a new algorithm for estimating SPR from DECT with noise suppression, using a pair of CT scans with spectral separation. The method is demonstrated using phantom measurements. MATERIALS AND METHODS An iterative algorithm is presented, reconstructing ED and EAN with noise suppression, based on Prior Image Constrained Denoising (PIC-D). The algorithm is tested using a Siemens Definition AS+ CT scanner (Siemens Healthcare, Forchheim, Germany). Three phantoms are investigated: a calibration phantom (CIRS 062M), a QA phantom (CATPHAN 700), and an anthropomorphic head phantom (CIRS 731-HN). A task-transfer function (TTF) and the noise power spectrum are derived from SPR images of the QA phantom for the evaluation of image quality. Comparisons of accuracy and noise for ED, EAN, and SPR are made for various versions of the algorithm in comparison to a solution based on Siemens syngo.via Rho/Z software and the current clinical standard of a single-energy CT stoichiometric calibration. A gamma analysis is also applied to the SPR images of the head phantom and water-equivalent distance (WED) is evaluated in a treatment planning system for a proton treatment field. RESULTS The algorithm is effective at suppressing noise in both ED and EAN and hence also SPR. The noise is tunable to a level equivalent to or lower than that of the syngo.via Rho/Z software. The spatial resolution (10% and 50% frequencies in the TTF) does not degrade even for the highest noise suppression investigated, although the average spatial frequency of noise does decrease. The PIC-D algorithm showed better accuracy than syngo.via Rho/Z for low density materials. In the calibration phantom, it was superior even when excluding lung substitutes, with root-mean-square deviations for ED and EAN less than 0.3% and 2%, respectively, compared to 0.5% and 3%. In the head phantom, however, the SPR accuracy of the PIC-D algorithm was comparable (excluding sinus tissue) to that derived from syngo.via Rho/Z: less than 1% error for soft tissue, brain, and trabecular bone substitutes and 5-7% for cortical bone, with the larger error for the latter likely related to the phantom geometry. Gamma evaluation showed that PIC-D can suppress noise in a patient-like geometry without introducing substantial errors in SPR. The absolute pass rates were almost identical for PIC-D and syngo.via Rho/Z. In the WED evaluations no general differences were shown. CONCLUSIONS The PIC-D DECT algorithm provides scanner-specific calibration and tunable noise suppression. It is vendor agnostic and applicable to any pair of CT scans with spectral separation. Improved accuracy to current methods was not clearly demonstrated for the complex geometry of a head phantom, but the suppression of noise without spatial resolution degradation and the possibility of incorporating constraints on image properties, suggests the usefulness of the approach.
Collapse
Affiliation(s)
- Jens Zimmerman
- Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden
- Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
| | - Daniel Thor
- Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden
- Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
| | - Gavin Poludniowski
- Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden
- Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
| |
Collapse
|
7
|
Stoichiometric CT number calibration using three-parameter fit model for ion therapy. Phys Med 2022; 99:22-30. [DOI: 10.1016/j.ejmp.2022.05.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/14/2022] [Revised: 05/06/2022] [Accepted: 05/15/2022] [Indexed: 11/19/2022] Open
|
8
|
Yasui K, Muramatsu R, Kamomae T, Toshito T, Kawabata F, Hayashi N. Evaluating the usefulness of the direct density reconstruction algorithm for intensity modulated and passively scattered proton therapy: Validation using an anthropomorphic phantom. Phys Med 2021; 92:95-101. [PMID: 34891108 DOI: 10.1016/j.ejmp.2021.11.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/11/2021] [Revised: 11/14/2021] [Accepted: 11/20/2021] [Indexed: 11/30/2022] Open
Abstract
PURPOSE Accurate calculation of the proton beam range inside a patient is an important topic in proton therapy. In recent times, a computed tomography (CT) image reconstruction algorithm was developed for treatment planning to reduce the impact of the variation of the CT number with changes in imaging conditions. In this study, we investigated the usefulness of this new reconstruction algorithm (DirectDensity™: DD) in proton therapy based on its comparison with filtered back projection (FBP). METHODS We evaluated the effects of variations in the X-ray tube potential and target size on the FBP- and DD-image values and investigated the usefulness of the DD algorithm based on the range variations and dosimetric quantity variations. RESULTS For X-ray tube potential variations, the range variation in the case of FBP was up to 12.5 mm (20.8%), whereas that of DD was up to 3.3 mm (5.6%). Meanwhile, for target size variations, the range variation in the case of FBP was up to 2.2 mm (2.5%), whereas that of DD was up to 0.9 mm (1.4%). Moreover, the variations observed in the case of DD were smaller than those of FBP for all dosimetric quantities. CONCLUSION The dose distributions obtained using DD were more robust against variations in the CT imaging conditions (X-ray tube potential and target size) than those obtained using FBP, and the range variations were often less than the dose calculation grid (2 mm). Therefore, the DD algorithm is effective in a robust workflow and reduces uncertainty in range calculations.
Collapse
Affiliation(s)
- Keisuke Yasui
- Fujita Health University, Faculty of Radiological Technology, School of Health Sciences, 1-98 Dengakugakubo Kutsukake-cho, Toyoake, Aichi 470-1192, Japan.
| | - Rie Muramatsu
- Nagoya Proton Therapy Center, Nagoya City University West Medical Center, 1-1-1 Hirate-cho Kita-ku, Nagoya, Aichi 462-8508, Japan
| | - Takeshi Kamomae
- Nagoya University Hospital, 65 Tsuruma-cho Shouwa-ku, Nagoya, Aichi 466-8560, Japan
| | - Toshiyuki Toshito
- Nagoya Proton Therapy Center, Nagoya City University West Medical Center, 1-1-1 Hirate-cho Kita-ku, Nagoya, Aichi 462-8508, Japan
| | - Fumitaka Kawabata
- Nagoya University Hospital, 65 Tsuruma-cho Shouwa-ku, Nagoya, Aichi 466-8560, Japan
| | - Naoki Hayashi
- Fujita Health University, Faculty of Radiological Technology, School of Health Sciences, 1-98 Dengakugakubo Kutsukake-cho, Toyoake, Aichi 470-1192, Japan
| |
Collapse
|
9
|
Bujila R, Omar A, Poludniowski G. A validation of SpekPy: A software toolkit for modelling X-ray tube spectra. Phys Med 2020; 75:44-54. [PMID: 32512239 DOI: 10.1016/j.ejmp.2020.04.026] [Citation(s) in RCA: 29] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/04/2020] [Revised: 04/14/2020] [Accepted: 04/26/2020] [Indexed: 11/16/2022] Open
Abstract
PURPOSE To validate the SpekPy software toolkit that has been developed to estimate the spectra emitted from tungsten anode X-ray tubes. The model underlying the toolkit introduces improvements upon a well-known semi-empirical model of X-ray emission. MATERIALS AND METHODS Using the same theoretical framework as the widely-used SpekCalc software, new electron penetration data was simulated using the Monte Carlo (MC) method, alternative bremsstrahlung cross-sections were applied, L-line characteristic emissions were included, and improvements to numerical methods implemented. The SpekPy toolkit was developed with the Python programming language. The toolkit was validated against other popular X-ray spectrum models (50 to 120 kVp), X-ray spectra estimated with MC (30 to 150 kVp) as well as reference half value layers (HVL) associated with numerous radiation qualities from standard laboratories (20 to 300 kVp). RESULTS The toolkit can be used to estimate X-ray spectra that agree with other popular X-ray spectrum models for typical configurations in diagnostic radiology as well as with MC spectra over a wider range of conditions. The improvements over SpekCalc are most evident at lower incident electron energies for lightly and moderately filtered radiation qualities. Using the toolkit, estimations of the HVL over a large range of standard radiation qualities closely match reference values. CONCLUSIONS A toolkit to estimate X-ray spectra has been developed and extensively validated for central-axis spectra. This toolkit can provide those working in Medical Physics and beyond with a powerful and user-friendly way of estimating spectra from X-ray tubes.
Collapse
Affiliation(s)
- Robert Bujila
- Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden; Department of Physics, Royal Institute of Technology, Stockholm, Sweden.
| | - Artur Omar
- Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
| | - Gavin Poludniowski
- Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
| |
Collapse
|
10
|
Nakao M, Ozawa S, Miura H, Yamada K, Habara K, Hayata M, Kusaba H, Kawahara D, Miki K, Nakashima T, Ochi Y, Tsuda S, Seido M, Morimoto Y, Kawakubo A, Nozaki H, Nagata Y. Development of a CT number calibration audit phantom in photon radiation therapy: A pilot study. Med Phys 2020; 47:1509-1522. [PMID: 32026482 PMCID: PMC7216906 DOI: 10.1002/mp.14077] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2019] [Revised: 01/30/2020] [Accepted: 01/31/2020] [Indexed: 01/24/2023] Open
Abstract
PURPOSE In photon radiation therapy, computed tomography (CT) numbers are converted into values for mass density (MD) or relative electron density to water (RED). CT-MD or CT-RED calibration tables are relevant for human body dose calculation in an inhomogeneous medium. CT-MD or CT-RED calibration tables are influenced by patient imaging (CT scanner manufacturer, scanning parameters, and patient size), the calibration process (tissue-equivalent phantom manufacturer, and selection of tissue-equivalent material), differences between tissue-equivalent materials and standard tissues, and the dose calculation algorithm applied; however, a CT number calibration audit has not been established. The purposes of this study were to develop a postal audit phantom, and to establish a CT number calibration audit process. METHODS A conventional stoichiometric calibration conducts a least square fit of the relationships between the MD, material weight, and measured CT number, using two parameters. In this study, a new stoichiometric CT number calibration scheme has been empirically established, using three parameters to harmonize the calculated CT number with the measured CT number for air and lung tissue. In addition, the suitable material set and the minimal number of materials required for stoichiometric CT number calibration were determined. The MDs and elemental weights from the International Commission on Radiological Protection Publication 110 were used as standard tissue data, to generate the CT-MD and CT-RED calibration tables. A small-sized, CT number calibration phantom was developed for a postal audit, and stoichiometric CT number calibration with the phantom was compared to the CT number calibration tables registered in the radiotherapy treatment planning systems (RTPSs) associated with five radiotherapy institutions. RESULTS When a least square fit was performed for the stoichiometric CT number calibration with the three parameters, the calculated CT number showed better agreement with the measured CT number. We established stoichiometric CT number calibration using only two materials because the accuracy of the process was determined not by the number of used materials but by the number of elements contained. The stoichiometric CT number calibration was comparable to the tissue-substitute calibration, with a dose difference less than 1%. An outline of the CT number calibration audit was demonstrated through a multi-institutional study. CONCLUSIONS We established a new stoichiometric CT number calibration method for validating the CT number calibration tables registered in RTPSs. We also developed a CT number calibration phantom for a postal audit, which was verified by the performances of multiple CT scanners located at several institutions. The new stoichiometric CT number calibration has the advantages of being performed using only two materials, and decreasing the difference between the calculated and measured CT numbers for air and lung tissue. In the future, a postal CT number calibration audit might be achievable using a smaller phantom.
Collapse
Affiliation(s)
- Minoru Nakao
- Hiroshima High‐Precision Radiotherapy Cancer Center3‐2‐2, Futabanosato, Higashi‐kuHiroshima732‐0057Japan
- Department of Radiation OncologyGraduate School of Biomedical & Health SciencesHiroshima University1‐2‐3 Kasumi, Minami‐kuHiroshima734‐8551Japan
| | - Shuichi Ozawa
- Hiroshima High‐Precision Radiotherapy Cancer Center3‐2‐2, Futabanosato, Higashi‐kuHiroshima732‐0057Japan
- Department of Radiation OncologyGraduate School of Biomedical & Health SciencesHiroshima University1‐2‐3 Kasumi, Minami‐kuHiroshima734‐8551Japan
| | - Hideharu Miura
- Hiroshima High‐Precision Radiotherapy Cancer Center3‐2‐2, Futabanosato, Higashi‐kuHiroshima732‐0057Japan
- Department of Radiation OncologyGraduate School of Biomedical & Health SciencesHiroshima University1‐2‐3 Kasumi, Minami‐kuHiroshima734‐8551Japan
| | - Kiyoshi Yamada
- Hiroshima High‐Precision Radiotherapy Cancer Center3‐2‐2, Futabanosato, Higashi‐kuHiroshima732‐0057Japan
| | - Kosaku Habara
- Hiroshima High‐Precision Radiotherapy Cancer Center3‐2‐2, Futabanosato, Higashi‐kuHiroshima732‐0057Japan
| | - Masahiro Hayata
- Hiroshima High‐Precision Radiotherapy Cancer Center3‐2‐2, Futabanosato, Higashi‐kuHiroshima732‐0057Japan
| | - Hayate Kusaba
- Hiroshima High‐Precision Radiotherapy Cancer Center3‐2‐2, Futabanosato, Higashi‐kuHiroshima732‐0057Japan
| | - Daisuke Kawahara
- Department of Radiation OncologyGraduate School of Biomedical & Health SciencesHiroshima University1‐2‐3 Kasumi, Minami‐kuHiroshima734‐8551Japan
| | - Kentaro Miki
- Department of Radiation OncologyHiroshima University Hospital1‐2‐3 Kasumi, Minami‐kuHiroshima734‐8551Japan
| | - Takeo Nakashima
- Radiation Therapy SectionDepartment of Clinical SupportHiroshima University Hospital1‐2‐3 Kasumi, Minami‐kuHiroshima734‐8551Japan
| | - Yusuke Ochi
- Radiation Therapy SectionDepartment of Clinical SupportHiroshima University Hospital1‐2‐3 Kasumi, Minami‐kuHiroshima734‐8551Japan
| | - Shintaro Tsuda
- Radiation Therapy SectionDepartment of Clinical SupportHiroshima University Hospital1‐2‐3 Kasumi, Minami‐kuHiroshima734‐8551Japan
| | - Mineaki Seido
- Department of RadiologyHiroshima Prefectural Hospital1‐5‐54, Ujinakanda, Minami‐kuHiroshima734‐8530Japan
| | - Yoshiharu Morimoto
- Department of RadiologyHiroshima Prefectural Hospital1‐5‐54, Ujinakanda, Minami‐kuHiroshima734‐8530Japan
| | - Atsushi Kawakubo
- Radiation Therapy DepartmentHiroshima City Hiroshima Citizens Hospital7‐33, Motomachi, Naka‐kuHiroshima730‐8518Japan
| | - Hiroshige Nozaki
- Division of RadiologyHiroshima Red Cross Hospital & Atomic‐bomb Survivors Hospital1‐9‐6, Senda, Naka‐kuHiroshima730‐8619Japan
| | - Yasushi Nagata
- Hiroshima High‐Precision Radiotherapy Cancer Center3‐2‐2, Futabanosato, Higashi‐kuHiroshima732‐0057Japan
- Department of Radiation OncologyGraduate School of Biomedical & Health SciencesHiroshima University1‐2‐3 Kasumi, Minami‐kuHiroshima734‐8551Japan
- Department of Radiation OncologyHiroshima University Hospital1‐2‐3 Kasumi, Minami‐kuHiroshima734‐8551Japan
| |
Collapse
|